Related Experiment Video
Updated: Jul 13, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: questioning
1Department of Neurology, University of Tennessee Health Sciences Center at Memphis, 855 Monroe Avenue, Link 415, Memphis, Tennessee 38163, USA.
Abstract:
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and membranous glomerulonephritis (MGN) are both autoimmune disorders that are rarely observed concurrently. We describe a patient who developed MGN nearly 20 years after the onset of CIDP, resulting in a secondary progression of his neuropathy. He responded dramatically to a novel regimen of plasma exchange and methotrexate. We propose a mechanism other than autoimmunity for the coincidence of these disorders and discuss the theoretical superiority of the treatment regimen that he received.
Insights
This case study details a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) who developed membranous glomerulonephritis (MGN) two decades later. A novel treatment combining plasma exchange and methotrexate proved effective for both conditions.
Area of Science:
- Neurology
- Nephrology
- Immunology
Background:
- Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and membranous glomerulonephritis (MGN) are distinct autoimmune disorders.
- Concurrent occurrence of CIDP and MGN is exceptionally rare in clinical practice.
Observation:
- A patient with a 20-year history of CIDP developed secondary membranous glomerulonephritis (MGN).
- The patient experienced a progression of neurological symptoms attributed to the development of MGN.
Findings:
- The patient demonstrated a dramatic response to a combined regimen of plasma exchange and methotrexate.
- A non-autoimmune mechanism is proposed for the simultaneous occurrence of CIDP and MGN in this case.
Implications:
- This case highlights a potential non-autoimmune link between CIDP and MGN.
- The described treatment regimen shows promise for managing co-occurring CIDP and MGN.
- Further research into the proposed mechanism could offer new therapeutic strategies.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Related Concept Videos
Multiple Sclerosis l: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Encephalitis ll: Pathophysiology